REFERENCES
- Lambert J R, Wright V. Eye inflammation in psoriatic arthritis. Ann Rheum Dis 1976; 35: 354
- Knox D L. Psoriasis and intraocular inflammation. Trans Am Ophthalmol Soc 1979; 127: 270
- Sfikakis P P, Theodossiadis P G, Katsiari C G, et al. Effect of infliximab on sight threatening panuveitis in Bechets disease. Lancet 2001; 358: 295–296
- Sfikakis P P, Kaklamanis P H, Elezoglou A, et al. Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Bechet disease. Ann Intern Med 2004; 140: 404–406
- Smith J A, Thompson D J, Whitcup S M, et al. A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis. Arthritis Rheum 2005; 53: 18–23
- Ali Y, Perlman E. Successful treatment of sarcoidosis. Ann Intern Med 2004; 140: W70
- Veale D J, Ritchlin C, Fitzgerald O. Immunopathology of psoriasis and psoriatic arthritis. Ann Rheum Dis 2005; 64: 26–29
- Forrester J V. Uveitis: pathogenesis. Lancet 1991; 338: 1498–1501
- De Vos A F, Hoekzema R, Kijlstra A. Cytokines and uveitis, a review. Curr Eye Res 1992; 11: 581–597
- Antoni C E, Kavanaugh A, Kirkham B, et al. Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT). Arthritis Rheum 2005; 52: 1227–1236
- Antoni C, Kruger G G, de Viam K, et al. Infliximab improves the signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial. Ann Rheum Dis 2005; 64: 1150–1157
- Mease P J, Goffe B S, Metz J, et al. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomized trial. Lancet 2000; 356: 385–390
- Mease P J, Kivitz A J, Burch F X, et al. Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression. Arthritis Rheum 2004; 50: 2264–2272
- Mease P J, Gladman D D, Ritchlin C T, et al. Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: results of a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2005; 52: 3279–3289
- Harper S L, Chorich L J, Foster C S. Diagnosis of uveitis. Diagnosis and Treatment of Uveitis, A Vitale, C S Foster. WB Sanders, Philadelphia 2002; 79–97
- Lindstedt E W, Baarsma G S, Kuijpers R W, et al. Anti-TNF-alpha therapy for sight threatening uveitis. Br J Ophthalmol 2005; 89: 533–536
- Suhler E B, Smith J R, Wertheim M S, et al. A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes. Arch Ophthalmol 2005; 123: 903–912
- Murphy C C, Ayliffe W H, Booth A, et al. Tumor necrosis factor alpha blockade with infliximab for refractory uveitis and scleritis. Ophthalmology 2004; 111: 352–356